Summit Global Investments »

Alnylam Pharmaceuticals shares owned by Summit Global Investments

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Summit Global Investments from 13F filings

Historical chart of Summit Global Investments investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Summit Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Summit Global Investments

Quarter filed Position value Share count Share price at filing
2025-03-31 $849k 3.1k 269.95